Results 211 to 220 of about 119,881 (373)

GVHD

Oncology Times, 2003
openaire   +2 more sources

Mechanistic approaches for the prevention and treatment of chronic GVHD.

Blood, 2017
C. Cutler, J. Koreth, J. Ritz
semanticscholar   +1 more source

Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation

Small Science, Volume 6, Issue 1, January 2026.
Tregs control immune tolerance but can also enable tumor escape. Nanomaterials can now expand or stabilize Tregs to treat autoimmunity and support transplantation or conversely disrupt tumor Tregs to boost antitumor immunity. We also discuss unintended Treg modulation by nanoparticles, safety and manufacturing challenges, and future translational ...
Yiyin Chen, Haibo Huang, Xiang Wang, Xinghao Yu, Ziyan Huang, Zhou Jin, Chen Chen, Yan Chen, Bruce R. Blazar, Yang Xu, Yunjie Lu   +10 more
wiley   +1 more source

The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes. [PDF]

Cancers (Basel)
Reda E, Kawari M, Pereira MP, Remberger M, Lau A, Law AD, Kumar R, Novitzky-Basso I, Lam W, Pasic I, Gerbitz A, Viswabandya A, Kim DD, Lipton JH, Mattsson J, Michelis FV.   +15 more
europepmc   +1 more source

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia [PDF]

, 2019
et al,, Uy, Geoffrey, Yeshurun, Moshe
core   +1 more source

Supplementary Table S2 from FDA Approval Summary: Axatilimab for Adult and Pediatric Patients Weighing at Least 40 Kilograms with Chronic GVHD after Two Prior Lines of Systemic Therapy [PDF]

Robert Q. Le, Kamar Godder, Jingyan Wang, Justin S. Collazo, Robyn Konicki, Moran Choe, Monica Feng, Donna Przepiorka, Jonathon Vallejo, Ankit Shah, Jiang Liu, Brenda J. Gehrke, Willie Wilson, Andrea Siegel, Yun Wu, Charles Yuan-Chia Kuo, Melissa Ray, Richard Pazdur, Marc R. Theoret, R. Angelo de Claro   +19 more
openalex   +1 more source

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

Proceedings of the National Academy of Sciences of the United States of America, 2018
B. Betts, D. Bastian, Supinya Iamsawat, Hung D. Nguyen, J. Heinrichs, Yongxia Wu, Anusara Daenthanasanmak, A. Veerapathran, A. O’Mahony, K. Walton, J. Reff, P. Horna, Elizabeth M. Sagatys, Marie Catherine Lee, J. Singer, Yingjun Chang, Chen Liu, J. Pidala, C. Anasetti, Xue-Zhong Yu   +19 more
semanticscholar   +1 more source

A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia

British Journal of Haematology, Volume 208, Issue 1, Page 39-53, January 2026.
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley   +1 more source

Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease. [PDF]

J Clin Med Res
Halahleh K, Sultan I, Abu-Khader A, Al-Far R, Halahleh L, Abdel Rahman Z, Muradi I, Khattab E, Abu Jazar H.   +8 more
europepmc   +1 more source

GvHD-Prophylaxe [PDF]

, 2017
Monika Engelhardt, Dietmar P. Berger, Roland Mertelsmann, Justus Duyster   +3 more
openaire   +1 more source